SBI Securities’s Maravai LifeSciences MRVI Stock Holding History

SBI Securities’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94K	Hold	311	–	–	﹤0.01%	2566
2026 Q1	$880	Hold	311	–	–	﹤0.01%	2702
2025 Q4	$1.01K	Sell	311 -103	-25%	-$347	﹤0.01%	2642
2025 Q3	$1.19K	Hold	414	–	–	﹤0.01%	2623
2025 Q2	$998	Buy	414 +90	+28%	+$189	﹤0.01%	2684
2025 Q1	$716	Sell	324 -85	-21%	-$336	﹤0.01%	2734
2024 Q4	$2.23K	Buy	+409	New	+$2.63K	﹤0.01%	2266

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

SBI Securities's MRVI Position: Q2 2026 in Review

SBI Securities held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 311 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

SBI Securities first reported a position in MRVI in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.23K in Q4 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

SBI Securities held 311 shares of Maravai LifeSciences worth $1.94K as of Q2 2026.
SBI Securities left its Maravai LifeSciences share count unchanged in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2566 holding.
SBI Securities first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Maravai LifeSciences position peaked at $2.23K in Q4 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.